MoneyWorks4Me

Gufic Biosciences gets NCLT’s nod for scheme of merger

07 Sep 2018 Evaluate

Gufic Biosciences has received an approval from the National Company Law Tribunal (NCLT) for the Scheme of Merger by absorption of Gufic Stridden Bio-Pharma with the company. The Mumbai Bench of the NCLT has on September 6, 2018, pronounced the order sanctioning of the same Scheme.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..